1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global Cancer Statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
2
|
Brenton JD, Carey LA, Ahmed AA and Caldas
C: Molecular classification and molecular forecasting of breast
cancer: ready for clinical application? J Clin Oncol. 23:7350–7360.
2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hudis CA and Gianni L: Triple-Negative
Breast Cancer: An Unmet Medical Need. Oncologist. 16:1–11. 2011.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Haffty BG, Yang Q, Reiss M, et al:
Locoregional relapse and distant metastasis in conservatively
managed triple negative early-stage breast cancer. J Clin Oncol.
24:5652–5657. 2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Dent R, Trudeau M, Pritchard KI, et al:
Triple-negative breast cancer: clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Keane MM, Ettenberg SA, Nau MM, Russell EK
and Lipkowitz S: Chemotherapy augments TRAIL induced apoptosis in
breast cell lines. Cancer Res. 59:734–741. 1999.PubMed/NCBI
|
7
|
Chinnaiyan AM, Prasad U, Shankar S, et al:
Combined effect of tumor necrosis factor-related apoptosis-inducing
ligand and ionizing radiation in breast cancer therapy. Proc Natl
Acad Sci USA. 97:1754–1759. 2000. View Article : Google Scholar : PubMed/NCBI
|
8
|
Walczak H, Miller RE, Ariail K, et al:
Tumoricidal activity of tumor necrosis factor-related
apoptosis-inducing ligand in vivo. Nat Med. 5:157–163. 1999.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Lirdprapamongkol K, Sakurai H, Suzuki S,
et al: Vanillin enhances TRAIL-induced apoptosis in cancer cells
through inhibition of NF-κB activation. In Vivo. 24:501–506.
2010.PubMed/NCBI
|
10
|
Lirdprapamongkol K, Sakurai H, Kawasaki N,
et al: Vanillin suppresses in vitro invasion and in vivo metastasis
of mouse breast cancer cells. Eur J Pharm Sci. 25:57–65. 2005.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Choo MK, Kawasaki N, Singhirunnusorn P, et
al: Blockade of transforming growth factor-beta-activated kinase 1
activity enhances TRAIL-induced apoptosis through activation of a
caspase cascade. Mol Cancer Ther. 5:2970–2976. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Falschlehner C, Emmerich CH, Gerlach B and
Walczak H: TRAIL signalling: decisions between life and death. Int
J Biochem Cell Biol. 39:1462–1475. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Burns TF and El-Deiry WS: Identification
of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive
colon carcinoma cell line SW480 using a genetic approach. J Biol
Chem. 276:37879–37886. 2001.PubMed/NCBI
|
14
|
Clohessy JG, Zhuang J, de Boer J,
Gil-Gómez G and Brady HJ: Mcl-1 interacts with truncated Bid and
inhibits its induction of cytochrome c release and its role in
receptor-mediated apoptosis. J Biol Chem. 281:5750–5759. 2006.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs
BS, Lindner DJ and Borden EC: Downregulation of Bcl-2, FLIP or IAPs
(XIAP and survivin) by siRNAs sensitizes resistant melanoma cells
to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 11:915–923.
2004. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ravi R and Bedi A: Potential methods to
circumvent blocks in apoptosis in lymphomas. Curr Opin Oncol.
14:490–503. 2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Shrader M, Pino MS, Lashinger L, Bar-Eli
M, Adam L, Dinney CP and McConkey DJ: Gefitinib reverses TRAIL
resistance in human bladder cancer cell lines via inhibition of
AKT-mediated X-linked inhibitor of apoptosis protein expression.
Cancer Res. 67:1430–1435. 2007. View Article : Google Scholar
|
18
|
Awale S, Ueda J, Athikomkulchai S,
Abdelhamed S, Yokoyama S, Saiki I and Miyatake R: Antiausterity
agents from Uvaria dac and their preferential cytotoxic
activity against human pancreatic cancer cell lines in a
nutrient-deprived condition. J Nat Prod. 75:1177–1183. 2012.
|
19
|
Taghizadeh Rabe SZ, Mahmoudi M, Ahi A and
Emami SA: Antiproliferative effects of extracts from Iranian
Artemisia species on cancer cell lines. Pharm Biol.
49:962–969. 2011.PubMed/NCBI
|